Article Versions Notes

Oikawa S, Mitomi H, Murai S, Nakayama A, Chiba S, Nishihara S, Ishii Y, Yamochi T, Yoshida H. Comparative Prognostic Roles of β-Catenin Expression and Tumor–Stroma Ratio in Pancreatic Cancer: Neoadjuvant Chemotherapy vs. Upfront Surgery. Current Oncology. 2025; 32(10):578. https://doi.org/10.3390/curroncol32100578

Oikawa, Shu, Hiroyuki Mitomi, So Murai, Akihiro Nakayama, Seiya Chiba, Shigetoshi Nishihara, Yu Ishii, Toshiko Yamochi, and Hitoshi Yoshida. 2025. "Comparative Prognostic Roles of β-Catenin Expression and Tumor–Stroma Ratio in Pancreatic Cancer: Neoadjuvant Chemotherapy vs. Upfront Surgery" Current Oncology 32, no. 10: 578. https://doi.org/10.3390/curroncol32100578

Oikawa, S., Mitomi, H., Murai, S., Nakayama, A., Chiba, S., Nishihara, S., Ishii, Y., Yamochi, T., & Yoshida, H. (2025). Comparative Prognostic Roles of β-Catenin Expression and Tumor–Stroma Ratio in Pancreatic Cancer: Neoadjuvant Chemotherapy vs. Upfront Surgery. Current Oncology, 32(10), 578. https://doi.org/10.3390/curroncol32100578